Date Filed | Type | Description |
06/09/2023 |
4
| Chu Shelley (Director) has filed a Form 4 on HilleVax, Inc.
Txns:
| Granted 22,500 options
@ $17.94, valued at
$403.7k
|
|
06/09/2023 |
4
| Cocero Nanette (Director) has filed a Form 4 on HilleVax, Inc.
Txns:
| Granted 11,000 options
@ $17.94, valued at
$197.3k
|
|
06/09/2023 |
4
| Gerberding Julie L. (Director) has filed a Form 4 on HilleVax, Inc.
Txns:
| Granted 22,500 options
@ $17.94, valued at
$403.7k
|
|
06/09/2023 |
4
| Sepulveda Jaime (Director) has filed a Form 4 on HilleVax, Inc.
Txns:
| Granted 22,500 options
@ $17.94, valued at
$403.7k
|
|
06/09/2023 |
4
| HILLEMAN JERYL L (Director) has filed a Form 4 on HilleVax, Inc.
Txns:
| Granted 22,500 options
@ $17.94, valued at
$403.7k
|
|
06/09/2023 |
4
| Heron Patrick J (10% Owner) has filed a Form 4 on HilleVax, Inc.
Txns:
| Granted 22,500 options
@ $17.94, valued at
$403.7k
|
|
05/10/2023 |
4
| Cocero Nanette (Director) has filed a Form 4 on HilleVax, Inc.
Txns:
| Granted 34,000 options to buy
@ $14.2, valued at
$482.8k
|
|
05/10/2023 |
3
| Cocero Nanette (Director) has filed a Form 3 on HilleVax, Inc. |
02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/10/2023 |
3
| Maltbie Shane (CFO) has filed a Form 3 on HilleVax, Inc. |
12/01/2022 |
4
| TAKEDA PHARMACEUTICAL CO LTD (10% Owner) has filed a Form 4 on HilleVax, Inc.
Txns:
| Exercised (in-or-at-the-money) 5,883,500 shares
@ $0 Exercised (in-or-at-the-money) 5,883,500 warrants
@ $0.0001, valued at
$588.4 |
|
08/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/23/2022 |
4
| Chu Shelley (Director) has filed a Form 4 on HilleVax, Inc.
Txns:
| Granted 25,000 options
@ $12.38, valued at
$309.5k
|
|
08/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/23/2022 |
4
| Sepulveda Jaime (Director) has filed a Form 4 on HilleVax, Inc.
Txns:
| Granted 25,000 options
@ $12.38, valued at
$309.5k
|
|
08/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/09/2022 |
3/A
| Form 3/A - Initial statement of beneficial ownership of securities: [Amend] |
05/03/2022 |
4
| Frazier Life Sciences X, L.P. (10% Owner) has filed a Form 4 on HilleVax, Inc.
Txns:
| Converted 2,736,234 shares
@ $13.6, valued at
$37.2M
Bought 1,764,706 shares
@ $17, valued at
$30M
Converted 37,212,796 convertible notes
@ $13.6, valued at
$506.1M
|
|
04/29/2022 |
3
| TAKEDA PHARMACEUTICAL CO LTD (10% Owner) has filed a Form 3 on HilleVax, Inc. |
04/28/2022 |
3
| Kohli Aditya (COO) has filed a Form 3 on HilleVax, Inc. |
04/28/2022 |
3
| HILLEMAN JERYL L (Director) has filed a Form 3 on HilleVax, Inc. |
04/28/2022 |
3
| Borkowski Astrid (Chief Medical Officer) has filed a Form 3 on HilleVax, Inc. |
04/28/2022 |
3
| Gerberding Julie L. (Director) has filed a Form 3 on HilleVax, Inc. |
04/28/2022 |
3
| Dubin Gary (Director) has filed a Form 3 on HilleVax, Inc. |
04/28/2022 |
3
| Sepulveda Jaime (Director) has filed a Form 3 on HilleVax, Inc. |
04/28/2022 |
3
| Frazier Life Sciences X, L.P. (10% Owner) has filed a Form 3 on HilleVax, Inc. |
04/28/2022 |
3
| Socks David A (CFO & Chief Business Officer) has filed a Form 3 on HilleVax, Inc. |
04/28/2022 |
3
| Chu Shelley (Director) has filed a Form 3 on HilleVax, Inc. |
04/28/2022 |
3
| HERSHBERG ROBERT (President and CEO) has filed a Form 3 on HilleVax, Inc. |
04/28/2022 |
3
| Silbermann Susan Michele (Director) has filed a Form 3 on HilleVax, Inc. |